LCTX vs REGN: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
LCTX
Lineage Cell Therapeutics Inc
—
REGN
Regeneron Pharmaceuticals Inc
$676.23
Key Metrics Comparison
| Metric | LCTX | REGN | Winner |
|---|---|---|---|
| Market Cap | $213.56M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze LCTX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or REGN a better investment?
Comparing LCTX and REGN: Lineage Cell Therapeutics Inc has a market cap of $213.56M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and REGN?
LCTX (Lineage Cell Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or REGN?
Both LCTX and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: LCTX or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: LCTX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $213.56M for LCTX.
Should I buy LCTX or REGN in 2026?
Both LCTX and REGN have investment merit. LCTX trades at $N/A while REGN trades at $676.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and REGN stock?
Key differences: Market Cap ($213.56M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy LCTX or REGN in 2026?
The choice between LCTX and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between LCTX and REGN?
LCTX (Lineage Cell Therapeutics Inc) has a market cap of $213.56M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.